2015
DOI: 10.1097/igc.0000000000000337
|View full text |Cite
|
Sign up to set email alerts
|

Chemotherapy Reduces Para-aortic Node Recurrences in Endometrial Cancer With Positive Pelvic and Unknown Para-aortic Nodes

Abstract: In the absence of local treatment (ie, para-aortic lymphadenectomy and radiotherapy), the administration of chemotherapy seems effective in reducing recurrences in the para-aortic area among patients with stage IIIC1 endometrioid EC.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
5
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 30 publications
1
5
0
Order By: Relevance
“…Indeed, LVSI is known to be associated with increased risk of distant‐recurrence in other types of gynecologic malignancy , and systemic chemotherapy is suggested for LVSI‐positive cases to reduce the risk of recurrence . In support of this rationale, another study reported that additional chemotherapy reduces the risk of para‐aortic lymph node recurrence among patients with pelvic lymph node metastasis, a surrogate marker for deep and extensive LVSI patterns found in our study .…”
Section: Discussionsupporting
confidence: 77%
“…Indeed, LVSI is known to be associated with increased risk of distant‐recurrence in other types of gynecologic malignancy , and systemic chemotherapy is suggested for LVSI‐positive cases to reduce the risk of recurrence . In support of this rationale, another study reported that additional chemotherapy reduces the risk of para‐aortic lymph node recurrence among patients with pelvic lymph node metastasis, a surrogate marker for deep and extensive LVSI patterns found in our study .…”
Section: Discussionsupporting
confidence: 77%
“…319 Multiple retrospective studies indicated a survival benefit in patients with advanced stage endometrial carcinoma treated with post-operative combined treatment including radiotherapy and chemotherapy, delivered by either the sandwich or sequential method, compared with radiotherapy alone or chemotherapy alone. [326][327][328][329][330][331][332][333][334][335][336][337][338][339][340][341][342][343][344] The benefit of added chemotherapy is unclear for patients with stage I-II clear cell carcinomas. These have often been included with serous as 'non-endometrioid carcinomas'.…”
Section: High Riskmentioning
confidence: 99%
“…The older pooled analysis of the NSGO-EORTC and MANGO-ILIADE trials used sequential chemotherapy and radiotherapy (either sequence) and reported significantly longer recurrence-free survival compared with radiotherapy alone 318 . Multiple retrospective studies indicated a survival benefit in advanced-stage endometrial carcinoma patients treated with post-operative combined treatment including radiotherapy and chemotherapy, delivered by either the sandwich or sequential method, compared to radiotherapy alone or chemotherapy alone [325][326][327][328][329][330][331][332][333][334][335][336][337][338][339][340][341][342][343] .…”
Section: High Riskmentioning
confidence: 99%